GO CAPITAL Research
Investment Thesis
GO CAPITAL is a Rennes-based, impact-oriented venture and growth capital manager founded in 2003. Its stated mission is to finance "sustainable innovation at the heart of the territories" — backing high-growth companies in digital, health, cleantech, industry, and the maritime/blue economy while explicitly prioritizing regional job creation and decentralized growth across western France. In June 2025 GO CAPITAL became a majority-owned subsidiary of Groupe MAGELLIM, a Paris-based impact private equity group managing roughly €4.4 billion, which gave GO CAPITAL additional capital firepower and access to a broader network while it retained its Rennes team and brand. Managing Partner Bertrand Distinguin has stated an ambition to grow the platform toward €1 billion dedicated to impact private equity. The firm organizes its activity around three complementary fund families: territorial development funds (regional seed-to-growth capital across sectors like health, digital, industrial transition), national/European sectoral impact funds (notably a maritime-economy-focused "Impact Océan Capital" fund and energy-transition vehicles), and advisory-mandate funds (including Mer Invest, Sud Mer Invest, and Odiem Capital) that extend GO CAPITAL's reach without direct fund ownership.
Sector Focus
GO CAPITAL invests across five core verticals: digital technology, healthcare/medtech, cleantech and energy transition, industrial/maritime technology, and the "blue economy" (économie de la mer) — a differentiated niche among French regional VCs. Recent portfolio additions illustrate this spread: BrightHeart (AI-assisted prenatal ultrasound), Alkion BioInnovations (industrial bioproduction of vaccine adjuvants), Axomove (digital rehabilitation medical device), Oxxius (laser photonics manufacturing), and Groupe Francbord (maritime and industrial technology, formed from the merger of Marinelec, Ecomer Data, and Enag).
Stage Focus
GO CAPITAL's territorial and impact funds together cover the full early-stage spectrum, from seed/capital-amorçage through growth-stage capital-développement. The firm positions itself as a leading early-stage technology investor in the Greater West of France, typically entering at seed or early Series A and reserving capital for follow-on support of existing portfolio lines.
Check Size
In 2025, GO CAPITAL deployed €25 million across 35 operations: €19.5 million into 13 new portfolio companies and €5.5 million reinforcing 22 existing lines — implying typical initial tickets in the low hundreds of thousands to a few million euros, with larger checks (€4-11 million rounds, usually co-invested) at growth stage. Recent disclosed round sizes GO CAPITAL participated in include Oxxius (€5M), Axomove (€4M), Alkion BioInnovations (€4.4M), Sirius Neosight (€4.4M, with Demeter), Olenbee (€7M), and BrightHeart (€11M Series A).
Lead Tendency
GO CAPITAL frequently co-invests alongside other funds (Demeter, Xplore by Épopée Gestion, Bpifrance-backed vehicles, France Angels networks) rather than consistently leading rounds solo, though it does anchor smaller territorial deals. Overall behavior reads as "both" — willing to lead early or regional deals, and to co-invest/follow in larger syndicated rounds.
Recent Activity
2025 was an active deployment year (€25M invested, 35 operations), and GO CAPITAL announced two new impact funds launching in 2026. Notable 2025-2026 investments include Alkion BioInnovations (Nov 2025), Grain de Sail (Nov 2025, via the Impact Océan Capital fund), Groupe Francbord (Jan 2026), BrightHeart (Jan 2026), Axomove (Apr 2026), and Oxxius (Sep 2026). The firm remains in active-deployment mode heading into its newly announced 2026 fund launches.
Portfolio Highlights
The public portfolio page lists 20+ companies spanning biotech (Abcely, Alkion BioInnovations), ocean/maritime tech (BiOceanOr, Grain de Sail, Groupe Francbord), digital/enterprise (Comeen, NeoXperiences, Appaloosa, Reelevant), medtech (Axomove, BrightHeart, Biophta), deeptech/hardware (Oxxius, Lactips, MoEa, iADYS, Sirius Neosight), and industrial/cleantech names (Flexikeg, Genevos, Olenbee, Aurora, Aisprid, Delivrone).
Team
GO CAPITAL's Directoire (executive board) comprises three Managing Partners:
- Bertrand Distinguin — Managing Partner
- Jérôme Gueret — Managing Partner
- Aude Kermarrec — Managing Partner
Additional partners identified in the investment team include:
- Frédéric Le Guillou — Partner, Venture Capital
- Leila Nicolas — Partner, healthcare investments
- David Leray — Partner, venture capital and startup growth
Decision Process
Investment decisions run through a partnership structure anchored by the three-person Directoire, consistent with a mid-sized regional management company overseeing multiple fund vehicles (territorial, impact-sectoral, and advisory-mandate funds).
Founder Preferences
GO CAPITAL favors technical and scientific founding teams building "responsible innovation" with a clear regional or sectoral anchor — deep tech, biotech, and industrial/maritime technology founders feature heavily, alongside digital-health and enterprise-software teams solving structuring, capital-intensive problems rather than pure consumer plays.
Geographic Focus
Historically focused on the Grand Ouest of France (Brittany, Pays de la Loire, Haute-Normandie), GO CAPITAL now operates from offices in Rennes, Paris, Bordeaux, Nantes, Caen, Orléans, Tours, and Marseille, reflecting a broadened national footprint since joining Groupe MAGELLIM, while its territorial funds retain a regional development mandate.